SI1909843T1 - Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field - Google Patents
Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical fieldInfo
- Publication number
- SI1909843T1 SI1909843T1 SI200632120A SI200632120A SI1909843T1 SI 1909843 T1 SI1909843 T1 SI 1909843T1 SI 200632120 A SI200632120 A SI 200632120A SI 200632120 A SI200632120 A SI 200632120A SI 1909843 T1 SI1909843 T1 SI 1909843T1
- Authority
- SI
- Slovenia
- Prior art keywords
- bioconjugates
- antitumoral
- hyaluronic acid
- pharmaceutical field
- chemical conjugation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000242A ITPD20050242A1 (en) | 2005-08-03 | 2005-08-03 | BIOCONIUGATI ANTITUMORALI OF HYALURONIC ACID OR ITS DERIVATIVES, OBTAINABLE FOR DIRECT OR INDIRECT CHEMICAL CONJUGATION, AND THEIR USE IN PHARMACEUTICAL FIELD |
| PCT/EP2006/007717 WO2007014784A2 (en) | 2005-08-03 | 2006-08-02 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation |
| EP06762981.6A EP1909843B1 (en) | 2005-08-03 | 2006-08-02 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1909843T1 true SI1909843T1 (en) | 2017-01-31 |
Family
ID=37038336
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200632189T SI2537533T1 (en) | 2005-08-03 | 2006-08-02 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation |
| SI200632187T SI2540319T1 (en) | 2005-08-03 | 2006-08-02 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation |
| SI200632120A SI1909843T1 (en) | 2005-08-03 | 2006-08-02 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200632189T SI2537533T1 (en) | 2005-08-03 | 2006-08-02 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation |
| SI200632187T SI2540319T1 (en) | 2005-08-03 | 2006-08-02 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9687558B2 (en) |
| EP (4) | EP2548582B1 (en) |
| JP (2) | JP5457672B2 (en) |
| KR (1) | KR101614157B1 (en) |
| CN (2) | CN103041402A (en) |
| AU (1) | AU2006274992B2 (en) |
| BR (1) | BRPI0614536A2 (en) |
| CA (1) | CA2616957C (en) |
| DK (2) | DK2540319T3 (en) |
| ES (4) | ES2633290T3 (en) |
| HK (1) | HK1118011A1 (en) |
| IL (1) | IL189078A0 (en) |
| IT (1) | ITPD20050242A1 (en) |
| NO (1) | NO20080564L (en) |
| NZ (1) | NZ565504A (en) |
| PL (3) | PL2540319T3 (en) |
| RU (1) | RU2411958C2 (en) |
| SI (3) | SI2537533T1 (en) |
| WO (1) | WO2007014784A2 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007004675A1 (en) * | 2005-07-06 | 2007-01-11 | Seikagaku Corporation | Drug-containing photocrosslinked hyaluronic acid derivative gel |
| ITMI20071267A1 (en) * | 2007-06-22 | 2008-12-23 | Fidia Farmaceutici | USE OF CONJUGATES OF HYALURONIC ACID IN LOCAL TREATMENT OF HYPERPROLIFERATIVE SKIN DISEASES |
| IE20070900A1 (en) * | 2007-12-12 | 2009-06-24 | Eurand Pharmaceuticals Ltd | New anticancer conjugates |
| US20120100218A1 (en) * | 2008-01-30 | 2012-04-26 | Laird Forrest | Intralymphatic Chemotherapy Drug Carriers |
| WO2009097570A2 (en) * | 2008-01-30 | 2009-08-06 | University Of Kansas | Intralymphatic chemotherapy drug carriers |
| IT1391006B1 (en) * | 2008-10-08 | 2011-10-27 | Fidia Farmaceutici | THERAPEUTIC USE OF NEW PHARMACEUTICAL PREPARATIONS CONTAINING ANTITUMOR DRUGS RELATED TO HYALURONIC ACID IN THE TREATMENT OF NEOPLASIA |
| RU2581972C2 (en) * | 2008-04-22 | 2016-04-20 | Фидия Фармачеутичи С.П.А. | Therapeutic application of new pharmaceutical preparations containing antineoplastic drugs, associated with hyaluronic acid, in treating neoplasms |
| KR20110032561A (en) * | 2009-09-23 | 2011-03-30 | 포항공과대학교 산학협력단 | Method of controling target specific drug delivery, target specific drug delivery system, and target non-specific long-acting drug delivery system |
| CN102399295B (en) | 2010-09-09 | 2013-11-06 | 常州百瑞吉生物医药有限公司 | Low-sulfhydrylation-modification-degree biocompatible high-molecular sulfhydrylation derivatives, cross-linking material thereof, and purpose thereof |
| WO2014172784A1 (en) * | 2013-04-25 | 2014-10-30 | Aluron Biopharma Inc. | Crosslinked hyaluronic acid compositions |
| WO2015005459A1 (en) * | 2013-07-10 | 2015-01-15 | 生化学工業株式会社 | Pharmaceutical composition for respiratory administration |
| CZ305153B6 (en) * | 2014-03-11 | 2015-05-20 | Contipro Biotech S.R.O. | Conjugates of hyaluronic acid oligomer or a salt thereof, process for their preparation and use |
| CN104497167B (en) * | 2014-11-24 | 2017-05-17 | 山东省药学科学院 | Hyaluronic acid derivative and therapeutic thereof |
| CN105727305B (en) * | 2016-02-24 | 2018-09-07 | 温州医科大学 | A kind of Legumain response release adriamycin slow release nanometer formulation and preparation method with as the application for preparing carrier medicament |
| CN108912245B (en) * | 2018-07-13 | 2020-04-28 | 吉林大学 | Fluorinated hyaluronic acid derivative with targeting and anti-inflammatory activities and preparation method and application thereof |
| US20220040318A1 (en) * | 2018-09-28 | 2022-02-10 | Seikagaku Corporation | Primary amine compound or secondary amine compound-acidic polysaccharide conjugate and production method therefor |
| AU2021289350B2 (en) * | 2020-06-08 | 2023-10-19 | Aihol Corporation | Uses of hyaluronan conjugate |
| CN111892668B (en) * | 2020-07-03 | 2022-07-12 | 广东工业大学 | Compound, preparation method thereof, fluorescent probe and antitumor drug |
| CN112089690A (en) * | 2020-08-31 | 2020-12-18 | 厦门大学 | Artesunate hyaluronate, nano micelle preparation thereof, preparation method and application thereof |
| CN112608397B (en) * | 2020-11-30 | 2021-12-28 | 西安交通大学 | Platinum antitumor drug-polysaccharide polymer nano prodrug and preparation method and application thereof |
| US20220401567A1 (en) * | 2021-06-18 | 2022-12-22 | Aihol Corporation | Uses of hyaluronan conjugate |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0138572B1 (en) | 1983-10-11 | 1990-07-25 | FIDIA S.p.A. | Hyaluronic acid fractions having pharmaceutical activity, methods for preparation thereof, and pharmaceutical compositions containing the same |
| US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| IT1219587B (en) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | SELF-CROSS-LINKED CARBOXYLY POLYSACCHARIDES |
| AU652784B2 (en) * | 1990-10-18 | 1994-09-08 | Shiseido Company Ltd. | Combination of hyaluronic acid with medicinal ingredient and production thereof |
| IT1247175B (en) | 1991-04-19 | 1994-12-12 | Fidia Spa | PROCEDURE FOR PURIFICATION OF HYALURONIC ACID AND FRACTION OF PURE HYALURONIC ACID FOR OPHTHALMIC USE. |
| AU4406793A (en) * | 1992-06-04 | 1993-12-30 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
| ES2149867T3 (en) | 1993-02-26 | 2000-11-16 | Drug Delivery System Inst Ltd | DERIVATIVES OF POLYSACCHARIDES AND SUPPORTS FOR PHARMACES. |
| US5616568A (en) * | 1993-11-30 | 1997-04-01 | The Research Foundation Of State University Of New York | Functionalized derivatives of hyaluronic acid |
| ITPD940054A1 (en) | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | SULPHATED POLYSACCHARIDES |
| CA2192725C (en) | 1995-12-28 | 2004-04-20 | Kenji Tsujihara | Camptothecin derivatives |
| HU226646B1 (en) | 1996-03-12 | 2009-05-28 | Pg Txl Company | Water soluble pharmaceutical compositions containing taxane derivatives |
| TW409058B (en) | 1996-06-06 | 2000-10-21 | Daiichi Seiyaku Co | Method for preparation of a drug complex |
| ITPD980169A1 (en) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | AMIDES OF HYALURONIC ACID AND ITS DERIVATIVES AND PROCESS FOR THEIR PREPARATION. |
| RU2002128610A (en) * | 2000-03-17 | 2004-03-27 | Селл Терапьютикс, Инк. (Us) | COMPOSITION OF POLYHLUTAMINE ACID CONJUGATES WITH CAMPTOTHETINE (OPTIONS) AND METHOD OF ITS PRODUCTION (OPTIONS), PHARMACEUTICAL COMPOSITION (OPTIONS) AND METHOD OF TREATING A LEUKLESA OR SUZHLO |
| GB0012718D0 (en) * | 2000-05-24 | 2000-07-19 | Angeletti P Ist Richerche Bio | Conjugates of aminodrugs |
| IT1317358B1 (en) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | CROSS-LINKATED DERIVATIVES OF HYALURONIC ACID. |
| IT1317359B1 (en) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | PERCARBOXYLATE POLYSACCHARIDES, SUCH AS HYALURONIC ACID, PROCESS FOR THEIR PREPARATION AND USE IN THE PHARMACEUTICAL FIELD AND |
| US20020197261A1 (en) | 2001-04-26 | 2002-12-26 | Chun Li | Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
| US20040234497A1 (en) * | 2001-05-04 | 2004-11-25 | Yi Luo | Hyaluronic acid containing bioconjugates:targeted delivery of anti-cancer drugs to cancer cells |
| US7034127B2 (en) * | 2002-07-02 | 2006-04-25 | Genzyme Corporation | Hydrophilic biopolymer-drug conjugates, their preparation and use |
| ITPD20020271A1 (en) * | 2002-10-18 | 2004-04-19 | Fidia Farmaceutici | CHEMICAL-PHARMACEUTICAL COMPOUNDS CONSISTING OF TAXAN DERIVATIVES COVALENTLY LINKED TO HYALURONIC ACID OR ITS DERIVATIVES. |
-
2005
- 2005-08-03 IT IT000242A patent/ITPD20050242A1/en unknown
-
2006
- 2006-08-02 AU AU2006274992A patent/AU2006274992B2/en active Active
- 2006-08-02 CN CN201210568694XA patent/CN103041402A/en active Pending
- 2006-08-02 EP EP11159664.9A patent/EP2548582B1/en active Active
- 2006-08-02 EP EP06762981.6A patent/EP1909843B1/en active Active
- 2006-08-02 ES ES11159629.2T patent/ES2633290T3/en active Active
- 2006-08-02 CN CN200680034187.0A patent/CN101267840B/en active Active
- 2006-08-02 EP EP11159629.2A patent/EP2537533B1/en active Active
- 2006-08-02 WO PCT/EP2006/007717 patent/WO2007014784A2/en active Application Filing
- 2006-08-02 EP EP11159649.0A patent/EP2540319B1/en active Active
- 2006-08-02 RU RU2008102878/05A patent/RU2411958C2/en active
- 2006-08-02 NZ NZ565504A patent/NZ565504A/en unknown
- 2006-08-02 SI SI200632189T patent/SI2537533T1/en unknown
- 2006-08-02 BR BRPI0614536-1A patent/BRPI0614536A2/en not_active IP Right Cessation
- 2006-08-02 ES ES11159664.9T patent/ES2692619T3/en active Active
- 2006-08-02 KR KR1020087004522A patent/KR101614157B1/en active IP Right Grant
- 2006-08-02 SI SI200632187T patent/SI2540319T1/en unknown
- 2006-08-02 DK DK11159649.0T patent/DK2540319T3/en active
- 2006-08-02 PL PL11159649T patent/PL2540319T3/en unknown
- 2006-08-02 ES ES11159649.0T patent/ES2633291T3/en active Active
- 2006-08-02 ES ES06762981.6T patent/ES2596877T3/en active Active
- 2006-08-02 PL PL06762981T patent/PL1909843T3/en unknown
- 2006-08-02 SI SI200632120A patent/SI1909843T1/en unknown
- 2006-08-02 CA CA2616957A patent/CA2616957C/en active Active
- 2006-08-02 PL PL11159629T patent/PL2537533T3/en unknown
- 2006-08-02 DK DK11159629.2T patent/DK2537533T3/en active
- 2006-08-02 JP JP2008524445A patent/JP5457672B2/en active Active
- 2006-08-02 US US11/989,716 patent/US9687558B2/en active Active
-
2008
- 2008-01-28 IL IL189078A patent/IL189078A0/en active IP Right Grant
- 2008-01-30 NO NO20080564A patent/NO20080564L/en not_active Application Discontinuation
- 2008-07-31 HK HK08108481.1A patent/HK1118011A1/en unknown
-
2013
- 2013-10-10 JP JP2013212756A patent/JP2014001249A/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1909843T3 (en) | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field | |
| IL185462A0 (en) | New pharmaceutical compositions useful in the treatment of pain | |
| IL225206A (en) | Polycyclic carbamoylpyridone derivative, pharmaceutical composition comprising the same and use thereof | |
| IL216599A (en) | 1,4-disubstituted phthalazine derivatives, pharmaceutical compositions comprising them and use thereof in the treatment of cancer | |
| HK1152055A1 (en) | Hyaluronic acid derivative and drug containing the same | |
| IL189737A0 (en) | Pyrazine derivatives, their preparation and pharmaceutical compositions containing them | |
| IL188050A (en) | Azaindazole derivatives, pharmaceutical compositions containing the same and uses thereof | |
| IL185484A0 (en) | Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents | |
| IL199151A (en) | Pyrimidine derivatives, pharmaceutical compositions comprising them, their use in the treatment of cancer and kits comprising them | |
| IL188494A0 (en) | Novel 2,4-dianlinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors | |
| IL189187A (en) | Polymer conjugates of k-252a and derivatives thereof, pharmaceutical compositions comprising the same and uses thereof | |
| IL193467A0 (en) | Substituted indazole derivatives, their manufacture and use as pharmaceutical agents | |
| EP2157093A4 (en) | Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof | |
| GB0523576D0 (en) | Drug composition and its use in therapy | |
| WO2006116221A3 (en) | Therapeutic combinations for the treatment or prevention of psychotic disorders | |
| IL201730A (en) | Derivatives of 1h-benzoimidazol-2-yl-propyl-methyl-amino-ethyl-5-aryl-bicyclo[2.2.2]oct-5-en-2-ol, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
| EP1916251A4 (en) | Erianin salts, their preparation methods and pharmaceutical compositions containing the same | |
| ZA200804163B (en) | New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions | |
| IL194880A (en) | Aminothiazole derivatives, their use in the treatment of diseases and pharmaceutical compositions comprising them | |
| PL1940840T3 (en) | 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof | |
| EP2196463A4 (en) | Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof | |
| PL1890695T3 (en) | Use of 2,5-disubstituted thiazol-4-one derivatives in drugs | |
| GB0501942D0 (en) | Cosmetic, veterinary, pharmaceutical and therapeutic compositions | |
| HK1120417A1 (en) | Stable nanoparticle formulations | |
| AP2010005435A0 (en) | 1,4-Naphthoquinone derivatives and therapeutic usethereof. |